BERLIN, Germany, September 29 /PRNewswire-FirstCall/ -- Schering AG, Germany (FSE: SCH , NYSE: SHR) announced today that the U.S. Food and Drug Administration (FDA) has approved Angeliq® to treat moderate to severe menopausal symptoms.
Angeliq® will be available in the U.S. by prescription in a preparation containing 0.5 mg drospirenone and 1 mg estradiol. Angeliq® is different from other available HRT in that it contains the anti-aldosterone progestin drospirenone. Anti-aldosterone activity has been shown to counter the excess water and sodium retention sometimes caused by estrogen. In addition, Angeliq® contains estradiol, the same estrogen produced by a woman's body prior to menopause.
"We have seen great success with our oral contraceptive Yasmin®, which also contains drospirenone. We look forward to offering Angeliq® to women in the U.S. as a new and unique option for treating menopause symptoms," said Philip Smits, M.D., Head of Gynecology&Andrology at Schering AG. "Angeliq® is already well accepted by women in Europe and we plan to launch it in the U.S. by mid-2006."
Additional information
Angeliq® quickly relieves the occurrence of vasomotor symptoms such as hot flashes and other symptoms of menopausal estrogen withdrawal, generally within four weeks of therapy initiation.
Angeliq® was studied in large-scale clinical trials involving 1,759 women that established the safety and efficacy in providing endometrial protection and an acceptable bleeding profile among post-menopausal women.
Schering AG is a research-based pharmaceutical company. Its activities are focused on four business areas: Gynecology&Andrology, Oncology, Diagnostic Imaging as well as Specialized Therapeutics for disabling diseases. As a global player with innovative products Schering AG aims for leading positions in specialized markets worldwide. With in-house R&D and supported by an excellent global network of external partners, Schering AG is securing a promising product pipeline. Using new ideas, Schering AG aims to make a recognized contribution to medical progress and strives to improve the quality of life: making medicine work This press release has been published by Corporate Communication of Schering AG, Berlin, Germany.
Your contacts at Corporate Communication: Media Relations: Oliver Renner , T: +49-30-468-124-31, oliver.renner@schering.de Investor Relations: Peter Vogt, T: +49-30-468-128-38, peter.vogt@schering.de Pharma Communication: Astrid Kranz, T: +49-30-468-120-57, astrid.kranz@schering.de Your contacts in the US: Media Relations: Kim Schillace, T:+1-973-487-2461, kimberly_schillace@berlex.com Investor Relations: Joanne Marion, T: +1-973-487-2164, joanne_marion@berlex.com Find additional information at: www.schering.de/eng Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and Schering AG's plans and objectives to differ materially from those expressed or implied in the forward-looking statements. Certain factors that may cause such differences are discussed in our Form 20-F and Form 6-K reports filed with the U.S. Securities and Exchange Commission. Schering AG undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events or circumstances or otherwise. Source: Schering Aktiengesellschaft
Thursday, September 29, 2005
Physicians Ill-prepared To Diagnose, Treat Bioterrorism Diseases
More than one-half of 631 physicians tested were unable to correctly diagnose diseases caused by agents most likely to be used by bioterrorists, such as smallpox, anthrax, botulism and plague, according to a Johns Hopkins study published in the Sept. 26 issue of Archives of Internal Medicine.
Related News Stories
Is Anthrax Just The Beginning? (October 19, 2001) -- Jim Matthews, an associate professor of pharmacy at Northeastern University's Bouvé College of Health Sciences, says that though the use of anthrax as a bioterrorist weapon is haunting, it is not ... > full story
Hopkins Center For Civilian Biodefense Studies Co-Sponsors Symposium On Medical/Public Health Response To Bioterrorism (February 10, 1999) -- With weapons of biological and chemical terrorism in the headlines and firmly on the nation's public agenda, political leaders, physicians, research scientists, as well as law enforcement and ... > full story
Balancing 'Hysteria And Suspicion': Doctors Face New Responsibilities In 'Bioterrorism Era' (December 27, 2004) -- The emergence of bioterrorism as a threat is creating new responsibilities for the medical community and, for the first time in history, is putting physicians at the forefront of managing disaster, ... > full story
FDA Approves New Plasma-derived Product To Treat Complications Of Smallpox Vaccination (March 3, 2005) -- The U.S. Food and Drug Administration has approved Vaccinia Immune Globulin Intravenous (VIGIV) -- the first intravenous human plasma-derived product available to treat certain rare complications of ... > full story
> more related stories
Related section:
Health & Medicine
However, test scores improved dramatically for the same physicians after they completed an online training course in diagnosing and managing these diseases caused by bioterrorism agents, according to the study.
"Most American physicians in practice today have never seen any cases of these diseases in their practice," explained Sara Cosgrove, M.D., M.S., a faculty member in Hopkins' Division of Infectious Diseases. "Preparation will be key to dealing with a major catastrophe, such as a major bioterrorist attack. Education and training healthcare providers in disease recognition, treatment and prevention strategies have the potential to significantly limit the effects of a bioterrorism attack."
In the study, 631 physicians at 30 internal medicine residency programs in 16 states and Washington, D.C. were tested on how to recognize and treat bioterrorism-related diseases before and after taking an online course in bioterrorism disease. On the pretest, correct diagnosis of diseases due to bioterrorism agents was smallpox, 50.7 percent; anthrax, 70.5 percent; botulism, 49.6 percent; and plague, 16.3 percent (average 46.8 percent), the researchers report. Correct diagnosis averaged 79.0 percent after completion of the course. Correct management of smallpox in the pretest was 14.6 percent; anthrax, 17.0 percent; botulism, 60.2 percent; and plague 9.7 percent (average 25.4 percent). Correct management averaged 79.1 percent after course completion.
Other Hopkins researchers involved in the study include Stephen Sisson, M.D., assistant professor of medicine; Trish Perl, M.D., M.Sc., associate professor of medicine and pathology and hospital epidemiologist; and Xiaoyan Song, M.D., assistant professor of medicine.
Editor's Note: The original news release can be found here.
-->
This story has been adapted from a news release issued by Johns Hopkins Medical Institutions.
Related News Stories
Is Anthrax Just The Beginning? (October 19, 2001) -- Jim Matthews, an associate professor of pharmacy at Northeastern University's Bouvé College of Health Sciences, says that though the use of anthrax as a bioterrorist weapon is haunting, it is not ... > full story
Hopkins Center For Civilian Biodefense Studies Co-Sponsors Symposium On Medical/Public Health Response To Bioterrorism (February 10, 1999) -- With weapons of biological and chemical terrorism in the headlines and firmly on the nation's public agenda, political leaders, physicians, research scientists, as well as law enforcement and ... > full story
Balancing 'Hysteria And Suspicion': Doctors Face New Responsibilities In 'Bioterrorism Era' (December 27, 2004) -- The emergence of bioterrorism as a threat is creating new responsibilities for the medical community and, for the first time in history, is putting physicians at the forefront of managing disaster, ... > full story
FDA Approves New Plasma-derived Product To Treat Complications Of Smallpox Vaccination (March 3, 2005) -- The U.S. Food and Drug Administration has approved Vaccinia Immune Globulin Intravenous (VIGIV) -- the first intravenous human plasma-derived product available to treat certain rare complications of ... > full story
> more related stories
Related section:
Health & Medicine
However, test scores improved dramatically for the same physicians after they completed an online training course in diagnosing and managing these diseases caused by bioterrorism agents, according to the study.
"Most American physicians in practice today have never seen any cases of these diseases in their practice," explained Sara Cosgrove, M.D., M.S., a faculty member in Hopkins' Division of Infectious Diseases. "Preparation will be key to dealing with a major catastrophe, such as a major bioterrorist attack. Education and training healthcare providers in disease recognition, treatment and prevention strategies have the potential to significantly limit the effects of a bioterrorism attack."
In the study, 631 physicians at 30 internal medicine residency programs in 16 states and Washington, D.C. were tested on how to recognize and treat bioterrorism-related diseases before and after taking an online course in bioterrorism disease. On the pretest, correct diagnosis of diseases due to bioterrorism agents was smallpox, 50.7 percent; anthrax, 70.5 percent; botulism, 49.6 percent; and plague, 16.3 percent (average 46.8 percent), the researchers report. Correct diagnosis averaged 79.0 percent after completion of the course. Correct management of smallpox in the pretest was 14.6 percent; anthrax, 17.0 percent; botulism, 60.2 percent; and plague 9.7 percent (average 25.4 percent). Correct management averaged 79.1 percent after course completion.
Other Hopkins researchers involved in the study include Stephen Sisson, M.D., assistant professor of medicine; Trish Perl, M.D., M.Sc., associate professor of medicine and pathology and hospital epidemiologist; and Xiaoyan Song, M.D., assistant professor of medicine.
Editor's Note: The original news release can be found here.
-->
This story has been adapted from a news release issued by Johns Hopkins Medical Institutions.
Sunday, September 25, 2005
Medisave for B1 and A wards Workers with healthy funds may also be able to tap them for chronic illness care
Tan Hui Lenghuileng@newstoday.com.sg
WORKERS who have healthy Medisave balances may soon be able to draw on their funds if they are admitted to B1 and A wards and private hospitals.
.The Ministry of Health is also looking into extending the usage of Medisave to the treatment of chronic diseases at government-run specialist outpatient clinics and private general practitioners.
.Health Minister Khaw Boon Wan made the announcements yesterday, after Prime Minister Lee Hsien Loong first signalled at the National Day Rally last month that such changes were in the works to make the scheme more flexible.
."For those who are working and have large Medisave balances, let's allow them to withdraw more money if they go into Class A, Class B1 or private wards," said Mr Khaw during a community visit to Kaki Bukit. No details are available yet, but the changes are expected to be finalised and implemented in the next few months.
.As for the possible extension of Medisave for use in long-term chronic illness treatment at government-run specialist outpatient clinics and private GPs, Mr Khaw noted that bills for the treatment of these diseases may not be small and, with repeat attendances, may run into thousands of dollars. Thus, he is looking into allowing working individuals with adequate Medisave to utilise the funds for this purpose. Details are expected early next year.
.The ministry is approaching this carefully, however, as Medisave is designed primarily for in-patient hospital stays and Mr Khaw is concerned that if the criteria for use in chronic disease treatment is too loose, the scheme may be abused and account holders may deplete their Medisave account and find themselves short of funds when hospitalised.
."I know very soon people will want screening, mammography and so on, and all this will grow … Nowadays you have very expensive screening tests which sometimes you wonder about their value," he said.
.With the raising of withdrawal limits for use in B1 and A wards and private hospitals, Mr Khaw said the Medisave contribution ceiling of $32,500 will also be reviewed and may be increased.
Tan Hui Lenghuileng@newstoday.com.sg
WORKERS who have healthy Medisave balances may soon be able to draw on their funds if they are admitted to B1 and A wards and private hospitals.
.The Ministry of Health is also looking into extending the usage of Medisave to the treatment of chronic diseases at government-run specialist outpatient clinics and private general practitioners.
.Health Minister Khaw Boon Wan made the announcements yesterday, after Prime Minister Lee Hsien Loong first signalled at the National Day Rally last month that such changes were in the works to make the scheme more flexible.
."For those who are working and have large Medisave balances, let's allow them to withdraw more money if they go into Class A, Class B1 or private wards," said Mr Khaw during a community visit to Kaki Bukit. No details are available yet, but the changes are expected to be finalised and implemented in the next few months.
.As for the possible extension of Medisave for use in long-term chronic illness treatment at government-run specialist outpatient clinics and private GPs, Mr Khaw noted that bills for the treatment of these diseases may not be small and, with repeat attendances, may run into thousands of dollars. Thus, he is looking into allowing working individuals with adequate Medisave to utilise the funds for this purpose. Details are expected early next year.
.The ministry is approaching this carefully, however, as Medisave is designed primarily for in-patient hospital stays and Mr Khaw is concerned that if the criteria for use in chronic disease treatment is too loose, the scheme may be abused and account holders may deplete their Medisave account and find themselves short of funds when hospitalised.
."I know very soon people will want screening, mammography and so on, and all this will grow … Nowadays you have very expensive screening tests which sometimes you wonder about their value," he said.
.With the raising of withdrawal limits for use in B1 and A wards and private hospitals, Mr Khaw said the Medisave contribution ceiling of $32,500 will also be reviewed and may be increased.
Tan Hui Lenghuileng@newstoday.com.sg
WORKERS who have healthy Medisave balances may soon be able to draw on their funds if they are admitted to B1 and A wards and private hospitals.
.The Ministry of Health is also looking into extending the usage of Medisave to the treatment of chronic diseases at government-run specialist outpatient clinics and private general practitioners.
.Health Minister Khaw Boon Wan made the announcements yesterday, after Prime Minister Lee Hsien Loong first signalled at the National Day Rally last month that such changes were in the works to make the scheme more flexible.
."For those who are working and have large Medisave balances, let's allow them to withdraw more money if they go into Class A, Class B1 or private wards," said Mr Khaw during a community visit to Kaki Bukit. No details are available yet, but the changes are expected to be finalised and implemented in the next few months.
.As for the possible extension of Medisave for use in long-term chronic illness treatment at government-run specialist outpatient clinics and private GPs, Mr Khaw noted that bills for the treatment of these diseases may not be small and, with repeat attendances, may run into thousands of dollars. Thus, he is looking into allowing working individuals with adequate Medisave to utilise the funds for this purpose. Details are expected early next year.
.The ministry is approaching this carefully, however, as Medisave is designed primarily for in-patient hospital stays and Mr Khaw is concerned that if the criteria for use in chronic disease treatment is too loose, the scheme may be abused and account holders may deplete their Medisave account and find themselves short of funds when hospitalised.
."I know very soon people will want screening, mammography and so on, and all this will grow … Nowadays you have very expensive screening tests which sometimes you wonder about their value," he said.
.With the raising of withdrawal limits for use in B1 and A wards and private hospitals, Mr Khaw said the Medisave contribution ceiling of $32,500 will also be reviewed and may be increased.
Tan Hui Lenghuileng@newstoday.com.sg
WORKERS who have healthy Medisave balances may soon be able to draw on their funds if they are admitted to B1 and A wards and private hospitals.
.The Ministry of Health is also looking into extending the usage of Medisave to the treatment of chronic diseases at government-run specialist outpatient clinics and private general practitioners.
.Health Minister Khaw Boon Wan made the announcements yesterday, after Prime Minister Lee Hsien Loong first signalled at the National Day Rally last month that such changes were in the works to make the scheme more flexible.
."For those who are working and have large Medisave balances, let's allow them to withdraw more money if they go into Class A, Class B1 or private wards," said Mr Khaw during a community visit to Kaki Bukit. No details are available yet, but the changes are expected to be finalised and implemented in the next few months.
.As for the possible extension of Medisave for use in long-term chronic illness treatment at government-run specialist outpatient clinics and private GPs, Mr Khaw noted that bills for the treatment of these diseases may not be small and, with repeat attendances, may run into thousands of dollars. Thus, he is looking into allowing working individuals with adequate Medisave to utilise the funds for this purpose. Details are expected early next year.
.The ministry is approaching this carefully, however, as Medisave is designed primarily for in-patient hospital stays and Mr Khaw is concerned that if the criteria for use in chronic disease treatment is too loose, the scheme may be abused and account holders may deplete their Medisave account and find themselves short of funds when hospitalised.
."I know very soon people will want screening, mammography and so on, and all this will grow … Nowadays you have very expensive screening tests which sometimes you wonder about their value," he said.
.With the raising of withdrawal limits for use in B1 and A wards and private hospitals, Mr Khaw said the Medisave contribution ceiling of $32,500 will also be reviewed and may be increased.
WORKERS who have healthy Medisave balances may soon be able to draw on their funds if they are admitted to B1 and A wards and private hospitals.
.The Ministry of Health is also looking into extending the usage of Medisave to the treatment of chronic diseases at government-run specialist outpatient clinics and private general practitioners.
.Health Minister Khaw Boon Wan made the announcements yesterday, after Prime Minister Lee Hsien Loong first signalled at the National Day Rally last month that such changes were in the works to make the scheme more flexible.
."For those who are working and have large Medisave balances, let's allow them to withdraw more money if they go into Class A, Class B1 or private wards," said Mr Khaw during a community visit to Kaki Bukit. No details are available yet, but the changes are expected to be finalised and implemented in the next few months.
.As for the possible extension of Medisave for use in long-term chronic illness treatment at government-run specialist outpatient clinics and private GPs, Mr Khaw noted that bills for the treatment of these diseases may not be small and, with repeat attendances, may run into thousands of dollars. Thus, he is looking into allowing working individuals with adequate Medisave to utilise the funds for this purpose. Details are expected early next year.
.The ministry is approaching this carefully, however, as Medisave is designed primarily for in-patient hospital stays and Mr Khaw is concerned that if the criteria for use in chronic disease treatment is too loose, the scheme may be abused and account holders may deplete their Medisave account and find themselves short of funds when hospitalised.
."I know very soon people will want screening, mammography and so on, and all this will grow … Nowadays you have very expensive screening tests which sometimes you wonder about their value," he said.
.With the raising of withdrawal limits for use in B1 and A wards and private hospitals, Mr Khaw said the Medisave contribution ceiling of $32,500 will also be reviewed and may be increased.
Tan Hui Lenghuileng@newstoday.com.sg
WORKERS who have healthy Medisave balances may soon be able to draw on their funds if they are admitted to B1 and A wards and private hospitals.
.The Ministry of Health is also looking into extending the usage of Medisave to the treatment of chronic diseases at government-run specialist outpatient clinics and private general practitioners.
.Health Minister Khaw Boon Wan made the announcements yesterday, after Prime Minister Lee Hsien Loong first signalled at the National Day Rally last month that such changes were in the works to make the scheme more flexible.
."For those who are working and have large Medisave balances, let's allow them to withdraw more money if they go into Class A, Class B1 or private wards," said Mr Khaw during a community visit to Kaki Bukit. No details are available yet, but the changes are expected to be finalised and implemented in the next few months.
.As for the possible extension of Medisave for use in long-term chronic illness treatment at government-run specialist outpatient clinics and private GPs, Mr Khaw noted that bills for the treatment of these diseases may not be small and, with repeat attendances, may run into thousands of dollars. Thus, he is looking into allowing working individuals with adequate Medisave to utilise the funds for this purpose. Details are expected early next year.
.The ministry is approaching this carefully, however, as Medisave is designed primarily for in-patient hospital stays and Mr Khaw is concerned that if the criteria for use in chronic disease treatment is too loose, the scheme may be abused and account holders may deplete their Medisave account and find themselves short of funds when hospitalised.
."I know very soon people will want screening, mammography and so on, and all this will grow … Nowadays you have very expensive screening tests which sometimes you wonder about their value," he said.
.With the raising of withdrawal limits for use in B1 and A wards and private hospitals, Mr Khaw said the Medisave contribution ceiling of $32,500 will also be reviewed and may be increased.
Tan Hui Lenghuileng@newstoday.com.sg
WORKERS who have healthy Medisave balances may soon be able to draw on their funds if they are admitted to B1 and A wards and private hospitals.
.The Ministry of Health is also looking into extending the usage of Medisave to the treatment of chronic diseases at government-run specialist outpatient clinics and private general practitioners.
.Health Minister Khaw Boon Wan made the announcements yesterday, after Prime Minister Lee Hsien Loong first signalled at the National Day Rally last month that such changes were in the works to make the scheme more flexible.
."For those who are working and have large Medisave balances, let's allow them to withdraw more money if they go into Class A, Class B1 or private wards," said Mr Khaw during a community visit to Kaki Bukit. No details are available yet, but the changes are expected to be finalised and implemented in the next few months.
.As for the possible extension of Medisave for use in long-term chronic illness treatment at government-run specialist outpatient clinics and private GPs, Mr Khaw noted that bills for the treatment of these diseases may not be small and, with repeat attendances, may run into thousands of dollars. Thus, he is looking into allowing working individuals with adequate Medisave to utilise the funds for this purpose. Details are expected early next year.
.The ministry is approaching this carefully, however, as Medisave is designed primarily for in-patient hospital stays and Mr Khaw is concerned that if the criteria for use in chronic disease treatment is too loose, the scheme may be abused and account holders may deplete their Medisave account and find themselves short of funds when hospitalised.
."I know very soon people will want screening, mammography and so on, and all this will grow … Nowadays you have very expensive screening tests which sometimes you wonder about their value," he said.
.With the raising of withdrawal limits for use in B1 and A wards and private hospitals, Mr Khaw said the Medisave contribution ceiling of $32,500 will also be reviewed and may be increased.
Tan Hui Lenghuileng@newstoday.com.sg
WORKERS who have healthy Medisave balances may soon be able to draw on their funds if they are admitted to B1 and A wards and private hospitals.
.The Ministry of Health is also looking into extending the usage of Medisave to the treatment of chronic diseases at government-run specialist outpatient clinics and private general practitioners.
.Health Minister Khaw Boon Wan made the announcements yesterday, after Prime Minister Lee Hsien Loong first signalled at the National Day Rally last month that such changes were in the works to make the scheme more flexible.
."For those who are working and have large Medisave balances, let's allow them to withdraw more money if they go into Class A, Class B1 or private wards," said Mr Khaw during a community visit to Kaki Bukit. No details are available yet, but the changes are expected to be finalised and implemented in the next few months.
.As for the possible extension of Medisave for use in long-term chronic illness treatment at government-run specialist outpatient clinics and private GPs, Mr Khaw noted that bills for the treatment of these diseases may not be small and, with repeat attendances, may run into thousands of dollars. Thus, he is looking into allowing working individuals with adequate Medisave to utilise the funds for this purpose. Details are expected early next year.
.The ministry is approaching this carefully, however, as Medisave is designed primarily for in-patient hospital stays and Mr Khaw is concerned that if the criteria for use in chronic disease treatment is too loose, the scheme may be abused and account holders may deplete their Medisave account and find themselves short of funds when hospitalised.
."I know very soon people will want screening, mammography and so on, and all this will grow … Nowadays you have very expensive screening tests which sometimes you wonder about their value," he said.
.With the raising of withdrawal limits for use in B1 and A wards and private hospitals, Mr Khaw said the Medisave contribution ceiling of $32,500 will also be reviewed and may be increased.
Subscribe to:
Posts (Atom)